Haleon (HLN) Accounts Payables (2021 - 2026)
Haleon's (HLN) quarterly Accounts Payables came in at -$5.1 billion in Q2 2026, down 1.91% on a QoQ basis from -$5.0 billion in Q4 2025.
Haleon (HLN) Accounts Payables (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Accounts Payables data on file, last reported at -$5.1 billion in Q2 2026.
- Quarterly Accounts Payables changed N/A year-over-year to -$5.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.1 billion (changed N/A YoY) and the FY2025 annual result came in at -$5.0 billion, down 204.76% from the prior year.
- Accounts Payables retreated to -$5.1 billion in Q2 2026, from -$5.0 billion in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $4.8 billion in Q4 2024 to a low of -$5.1 billion in Q2 2026.
- A 5-year average of -$1.3 billion and a median of -$4.4 billion in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables grew 8.66% — and 2025, when it plunged 205.09%.
- Tracing HLN's Accounts Payables over 5 years: stood at $4.2 billion in 2022, then increased by 3.04% to $4.4 billion in 2023, then rose by 8.66% to $4.8 billion in 2024, then sank by 205.09% to -$5.0 billion in 2025, then slipped by 1.91% to -$5.1 billion in 2026.
- The last three Accounts Payables figures came in at -$5.1 billion (Q2 2026), -$5.0 billion (Q4 2025), and $4.8 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.09 Bn |
| Dec 31, 2025 | -5.00 Bn |
| Dec 31, 2024 | 4.76 Bn |
| Jun 30, 2024 | -4.54 Bn |
| Dec 31, 2023 | 4.38 Bn |
| Jun 30, 2023 | -4.39 Bn |
| Dec 31, 2022 | 4.25 Bn |
| Jun 30, 2022 | -4.47 Bn |
| Dec 31, 2021 | 4.05 Bn |